Table 3.
Variation of Pulmonary Artery Diameter According to Categorical Outcomes
| Group | Categories | Group size | PAD at baseline NCCT (mm) (m±SD) | Effect size | P value |
|---|---|---|---|---|---|
| Mortality | No | 379 | 26.5±3.7 | 0.011 | .072 |
| COVID-19–related | 74 | 27.4±4.1 | |||
| not COVID-19–related | 12 | 28.3±4.1 | |||
| All-cause mortality | No | 379 | 26.5±3.7 | 0.256 | .033 |
| Yes | 86 | 27.5±4.1 | |||
| ICU Admission | No | 355 | 26.5±3.7 | 0.205 | .061 |
| Yes | 110 | 27.3±3.9 | |||
| Invasive mechanical ventilation | No | 395 | 26.5±3.8 | 0.285 | .028 |
| Yes | 70 | 27.6±3.9 | |||
| PCFS at dischargea | PCFS 0-2 | 265 | 26.4±3.7 | 0.090 | .441 |
| PCFS 3-4 | 103 | 26.7±3.8 | |||
| PCFS at 2-montha | PCFS 0-2 | 335 | 26.4±3.6 | 0.409 | .032 |
| PCFS 3-4 | 30 | 27.9±4.5 |
ICU, Intensive care unit; PAD, pulmonary artery diameter; PCFS, Post–COVID-19 Functional Status scale.P values correspond to analysis of variance and Student t test. The used effect sizes are Cohen’s d for the t test and eta squared for analysis of variance test.
a
The group sizes are slightly less than the number of survivors due to missing data.